Acuta Capital Partners’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-121,692
| Closed | -$834K | – | 39 |
|
|
2023
Q3 | $834K | Hold |
121,692
| – | – | 0.56% | 30 |
|
|
2023
Q2 | $1.26M | Sell |
121,692
-148
| -0.1% | -$1.54K | 0.86% | 25 |
|
|
2023
Q1 | $986K | Sell |
121,840
-133,160
| -52% | -$1.08M | 0.73% | 19 |
|
|
2022
Q4 | $4.02M | Buy |
255,000
+94,165
| +59% | +$1.48M | 2.47% | 18 |
|
|
2022
Q3 | $2.53M | Sell |
160,835
-32,000
| -17% | -$504K | 1.09% | 23 |
|
|
2022
Q2 | $2.69M | Sell |
192,835
-24,765
| -11% | -$346K | 1.5% | 23 |
|
|
2022
Q1 | $3.75M | Buy |
217,600
+119,600
| +122% | +$2.06M | 1.75% | 21 |
|
|
2021
Q4 | $1.43M | Sell |
98,000
-42,839
| -30% | -$623K | 0.6% | 31 |
|
|
2021
Q3 | $2.54M | Sell |
140,839
-34,161
| -20% | -$615K | 0.89% | 30 |
|
|
2021
Q2 | $3.07M | Sell |
175,000
-142,730
| -45% | -$2.51M | 1.23% | 27 |
|
|
2021
Q1 | $8.01M | Buy |
+317,730
| New | +$8.01M | 2.89% | 12 |
|
|
2018
Q1 | – | Sell |
-92,500
| Closed | -$2.28M | – | 32 |
|
|
2017
Q4 | $2.28M | Buy |
+92,500
| New | +$2.28M | 0.43% | 24 |
|
|
2017
Q3 | – | Sell |
-90,000
| Closed | -$2.44M | – | 36 |
|
|
2017
Q2 | $2.44M | Sell |
90,000
-110,000
| -55% | -$2.98M | 0.68% | 23 |
|
|
2017
Q1 | $5.96M | Sell |
200,000
-172,753
| -46% | -$5.15M | 1.41% | 15 |
|
|
2016
Q4 | $10.1M | Buy |
+372,753
| New | +$10.1M | 3.76% | 10 |
|